Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2025-12-24 @ 10:54 PM
NCT ID:
NCT06907069
Eligibility Criteria:
Inclusion Criteria:
1. Voluntarily participate in the study and sign the informed consent;
2. Inpatients aged 18-80 years old, regardless of gender;
3. Patients who met the diagnostic criteria for pulmonary infection in the Guidelines for the Diagnosis and Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia for Adults in China (2018 Edition);
4. Infections caused by Gram-negative bacteria (CRO) that are known or strongly suspected to be resistant to carbapenems but sensitive to CMS.
Exclusion Criteria:
1. Age \> 80 years old;
2. The patient had a history of severe allergy or hypersensitivity to polymyxins;
3. Patients with serious dysfunction of heart, liver, kidney and other important organs;
4. Patients with serious diseases such as malignant tumors and blood system diseases;
5. Patients with low immune function and risk of opportunistic pathogen infection;
6. Patients who used excessive colistin intravenous or atomized inhalation therapy within 72h before enrollment;
7. Have participated in other clinical trials within three months;
8. Pregnant or breastfeeding women;
9. There are other circumstances that the researcher believes are not suitable for inclusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06907069
Study Brief:
Protocol Section:
NCT06907069